3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Sarcoma
18
Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Ovarian Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Liposarcoma
5
Leiomyosarcoma
5
Hemangiosarcoma
5
Sarcoma, Synovial
4
Neurofibrosarcoma
4
Lung Neoplasms
4
Kidney Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Urinary Bladder Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Glioblastoma
3
Thyroid Carcinoma, Anaplastic
2
Small Cell Lung Carcinoma
2
Sarcoma, Alveolar Soft Part
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Melanoma
2
Gliosarcoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
selpercatinib
2
dabrafenib
2
Sorafenib
2
Fluorodeoxyglucose F18
2
AZD 6244
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tovorafenib
1
tanespimycin
1
romidepsin
1
pralsetinib
1
pembrolizumab
1
omipalisib
1
durvalumab
1
copanlisib
1
cediranib
1
alectinib
1
aflibercept
1
Vorinostat
1
Vemurafenib
1
Thyrotropin Alfa
1
Thyroidectomy
1
Thyroid (USP)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Cancer, Papillary
×
pazopanib
×
Clear all
No trials found.